AmpliTech Group announced a board-approved stock repurchase program allowing up to $10 million in buybacks over 24 months, signaling confidence in its record revenue and expanding order book. Concurrently, the company terminated its At-The-Market equity offering, citing a strong balance sheet and sufficient cash to fund growth without issuing new shares. This move reflects AmpliTech's commitment to disciplined capital allocation and returning value to shareholders while supporting ongoing expansion in advanced RF and 5G technologies.
YieldMax ETFs announced their weekly distributions for Group 1 option income ETFs, with payments scheduled for July 9, 2026. The distributions vary by ETF, with rates ranging from about 24.75% to over 60% annualized, reflecting income generated prima...
YieldMax declared monthly distributions for its Target 12™ ETFs: BIGY (Big 50 Option Income), RNTY (Real Estate Option Income), and SOXY (Semiconductor Option Income). Each ETF targets a 12% annual income level, with distributions scheduled for July ...
The global Transthyretin Amyloidosis Treatment Market, valued at $8.95 billion in 2025, is projected to reach $35.10 billion by 2035 with a CAGR of 14.64%. Growth is fueled by advances in gene-silencing RNAi therapies like patisiran and vutrisiran, i...
The AI legal drafting tools market is projected to expand rapidly from $0.9 billion in 2025 to $3.42 billion by 2030, with a CAGR of about 30.7%. Growth is fueled by increasing demand for automation in legal processes, adoption of AI-powered contract...
Tower Semiconductor announced it will publish its second quarter 2026 financial results on August 4, 2026, followed by a conference call to discuss the earnings and provide guidance for the third quarter. The call will be webcast and accessible via t...
